Top Markets
Coin of the day
Tricida, Inc. Tricida, Inc.

Tricida, Inc.

TCDA
Rankning i aktier #35026
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the... Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
Aktiekurs
$0.108
Senast synkroniserad: 2023-01-23
Marknadsvärde
$4.56M
Förändring (1 dag)
-10.00%
Förändring (1 år)
0.00%
Land
US
Handel Tricida, Inc. (TCDA)

Kategori

Historik för aktiesplit för Tricida, Inc. (TCDA)
Aktien Tricida, Inc. (symbol: TCDA) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 16, 2026.
En TCDA-aktie köpt före Aug 16, 2026 motsvarar nu 0 TCDA-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE